HEADER HYDROLASE/HYDROLASE INHIBITOR 16-NOV-16 5PB5 TITLE HUMAN FACTOR VIIA IN COMPLEX WITH 1-[[3-[5-HYDROXY-4-(7H-PYRROLO[2,3- TITLE 2 D]PYRIMIDIN-6-YL)PYRAZOL-1-YL]PHENYL]METHYL]-3-PHENYLUREA AT 1.84A COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR VII LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROCONVERTIN,SERUM PROTHROMBIN CONVERSION ACCELERATOR,SPCA; COMPND 5 EC: 3.4.21.21; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: COAGULATION FACTOR VII HEAVY CHAIN; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: PROCONVERTIN,SERUM PROTHROMBIN CONVERSION ACCELERATOR,SPCA; COMPND 11 EC: 3.4.21.21; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: F7; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION KEYWDS 2 FACTOR, PROTEIN INHIBITOR COMPLEX, CALCIUM-BINDING, HYDROLASE- KEYWDS 3 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.STIHLE,A.MAYWEG,S.ROEVER,M.G.RUDOLPH REVDAT 4 03-APR-24 5PB5 1 REMARK REVDAT 3 17-NOV-21 5PB5 1 REMARK REVDAT 2 21-FEB-18 5PB5 1 REMARK REVDAT 1 21-JUN-17 5PB5 0 JRNL AUTH A.MAYWEG,S.ROEVER,M.G.RUDOLPH JRNL TITL CRYSTAL STRUCTURE OF A FACTOR VIIA COMPLEX JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0077 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 43544 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2320 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.84 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.89 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2410 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 74.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.3260 REMARK 3 BIN FREE R VALUE SET COUNT : 131 REMARK 3 BIN FREE R VALUE : 0.3210 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2346 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 314 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.38000 REMARK 3 B22 (A**2) : -0.38000 REMARK 3 B33 (A**2) : 0.77000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.102 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.095 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.059 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.894 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2518 ; 0.010 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1684 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3440 ; 1.427 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4077 ; 2.055 ; 3.008 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 316 ; 6.466 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;27.585 ;23.084 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 400 ;13.883 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;16.859 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 375 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2806 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 504 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1533 ; 0.693 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 631 ; 0.119 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2484 ; 1.303 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 985 ; 1.662 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 950 ; 2.850 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE NUMBERING FOLLOWS THAT OF THE REMARK 3 UNPROCESSED PRECURSOR GLN426 OMITTED DUE TO LACK OF CLEAR REMARK 3 ELECTRON DENSITY. HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5PB5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1001400441. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54177 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SADABS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46187 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.840 REMARK 200 RESOLUTION RANGE LOW (A) : 49.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 9.570 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : 0.06300 REMARK 200 FOR THE DATA SET : 22.2200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.1 REMARK 200 DATA REDUNDANCY IN SHELL : 7.07 REMARK 200 R MERGE FOR SHELL (I) : 0.36300 REMARK 200 R SYM FOR SHELL (I) : 0.36300 REMARK 200 FOR SHELL : 4.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INHOUSE MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16 MG/ML PROTEIN IN 20MM TRIS/HCL PH REMARK 280 8.4, 5 MM BENZAMIDINE, 0.1 M NACL, 50 MM CACL2 MIXED 1+1 WITH 32- REMARK 280 35% AMMONIUM SULPHATE, 2% PEG 4000, 0.1 M BICINE-NAOH PH 8.5, 15% REMARK 280 GLYCEROL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.25600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.51850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.51850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.12800 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.51850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.51850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 87.38400 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.51850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.51850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 29.12800 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.51850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.51850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 87.38400 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.25600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 847 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 857 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 149 REMARK 465 SER A 207 REMARK 465 LYS A 208 REMARK 465 PRO A 209 REMARK 465 GLN A 210 REMARK 465 GLY A 211 REMARK 465 ARG A 212 REMARK 465 LYS B 376 REMARK 465 VAL B 377 REMARK 465 GLY B 378 REMARK 465 ASP B 379 REMARK 465 SER B 380 REMARK 465 PRO B 381 REMARK 465 GLN B 426 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 375 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 706 O HOH B 823 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 160 -109.39 -123.91 REMARK 500 THR A 168 37.26 -88.79 REMARK 500 SER B 250 -159.87 -138.63 REMARK 500 LYS B 259 -62.84 -94.75 REMARK 500 HIS B 271 -69.50 -144.49 REMARK 500 THR B 332 -58.58 -129.26 REMARK 500 SER B 423 -135.31 -102.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 502 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 270 OE1 REMARK 620 2 ASP B 272 O 88.8 REMARK 620 3 GLU B 275 O 150.7 77.7 REMARK 620 4 GLU B 280 OE2 105.3 165.6 90.9 REMARK 620 5 HOH B 656 O 84.5 100.7 72.9 84.0 REMARK 620 6 HOH B 774 O 89.9 86.4 114.7 90.4 170.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9RY B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CA B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 505 DBREF 5PB5 A 149 212 UNP P08709 FA7_HUMAN 149 212 DBREF 5PB5 B 213 466 UNP P08709 FA7_HUMAN 213 466 SEQRES 1 A 64 LEU ILE CYS VAL ASN GLU ASN GLY GLY CYS GLU GLN TYR SEQRES 2 A 64 CYS SER ASP HIS THR GLY THR LYS ARG SER CYS ARG CYS SEQRES 3 A 64 HIS GLU GLY TYR SER LEU LEU ALA ASP GLY VAL SER CYS SEQRES 4 A 64 THR PRO THR VAL GLU TYR PRO CYS GLY LYS ILE PRO ILE SEQRES 5 A 64 LEU GLU LYS ARG ASN ALA SER LYS PRO GLN GLY ARG SEQRES 1 B 254 ILE VAL GLY GLY LYS VAL CYS PRO LYS GLY GLU CYS PRO SEQRES 2 B 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS SEQRES 3 B 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA SEQRES 4 B 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU SEQRES 5 B 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP SEQRES 6 B 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE SEQRES 7 B 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE SEQRES 8 B 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP SEQRES 9 B 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER SEQRES 10 B 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER SEQRES 11 B 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU SEQRES 12 B 254 GLU LEU MET VAL LEU ASN VAL PRO ARG LEU MET THR GLN SEQRES 13 B 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO SEQRES 14 B 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP SEQRES 15 B 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO SEQRES 16 B 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY SEQRES 17 B 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS SEQRES 18 B 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP SEQRES 19 B 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL SEQRES 20 B 254 LEU LEU ARG ALA PRO PHE PRO HET GOL A 301 6 HET 9RY B 501 32 HET CA B 502 1 HET CL B 503 1 HET SO4 B 504 5 HET SO4 B 505 5 HETNAM GOL GLYCEROL HETNAM 9RY N-({3-[5-HYDROXY-4-(7H-PYRROLO[2,3-D]PYRIMIDIN-6-YL)- HETNAM 2 9RY 1H-PYRAZOL-1-YL]PHENYL}METHYL)-N'-PHENYLUREA HETNAM CA CALCIUM ION HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL C3 H8 O3 FORMUL 4 9RY C23 H19 N7 O2 FORMUL 5 CA CA 2+ FORMUL 6 CL CL 1- FORMUL 7 SO4 2(O4 S 2-) FORMUL 9 HOH *314(H2 O) HELIX 1 AA1 ASN A 153 CYS A 158 5 6 HELIX 2 AA2 ILE A 198 LYS A 203 1 6 HELIX 3 AA3 ALA B 251 ASP B 256 5 6 HELIX 4 AA4 ASN B 260 ARG B 262 5 3 HELIX 5 AA5 GLU B 325 THR B 332 1 8 HELIX 6 AA6 LEU B 333 VAL B 336 5 4 HELIX 7 AA7 MET B 366 GLN B 373 1 8 HELIX 8 AA8 TYR B 443 ARG B 452 1 10 SHEET 1 AA1 2 TYR A 161 HIS A 165 0 SHEET 2 AA1 2 LYS A 169 ARG A 173 -1 O SER A 171 N SER A 163 SHEET 1 AA2 2 TYR A 178 LEU A 180 0 SHEET 2 AA2 2 CYS A 187 PRO A 189 -1 O THR A 188 N SER A 179 SHEET 1 AA3 8 LYS B 217 VAL B 218 0 SHEET 2 AA3 8 MET B 358 LEU B 365 -1 O VAL B 359 N LYS B 217 SHEET 3 AA3 8 MET B 387 ALA B 390 -1 O CYS B 389 N LEU B 365 SHEET 4 AA3 8 GLY B 435 ARG B 439 -1 O TYR B 437 N PHE B 388 SHEET 5 AA3 8 THR B 415 VAL B 422 -1 N ILE B 421 O THR B 438 SHEET 6 AA3 8 PRO B 407 TYR B 412 -1 N TYR B 412 O THR B 415 SHEET 7 AA3 8 PHE B 338 GLY B 343 -1 N LEU B 340 O ALA B 409 SHEET 8 AA3 8 MET B 358 LEU B 365 -1 O VAL B 362 N SER B 339 SHEET 1 AA4 8 LEU B 460 ALA B 463 0 SHEET 2 AA4 8 GLN B 281 PRO B 291 1 N VAL B 288 O LEU B 461 SHEET 3 AA4 8 ALA B 304 LEU B 308 -1 O LEU B 305 N ILE B 289 SHEET 4 AA4 8 TRP B 247 SER B 250 -1 N VAL B 248 O LEU B 306 SHEET 5 AA4 8 ALA B 235 LEU B 242 -1 N THR B 241 O VAL B 249 SHEET 6 AA4 8 GLN B 227 VAL B 232 -1 N LEU B 230 O CYS B 238 SHEET 7 AA4 8 LEU B 264 LEU B 268 -1 O VAL B 267 N LEU B 229 SHEET 8 AA4 8 GLN B 281 PRO B 291 -1 O GLN B 281 N LEU B 268 SSBOND 1 CYS A 151 CYS A 162 1555 1555 2.03 SSBOND 2 CYS A 158 CYS A 172 1555 1555 2.03 SSBOND 3 CYS A 174 CYS A 187 1555 1555 2.03 SSBOND 4 CYS A 195 CYS B 322 1555 1555 2.02 SSBOND 5 CYS B 219 CYS B 224 1555 1555 2.03 SSBOND 6 CYS B 238 CYS B 254 1555 1555 2.04 SSBOND 7 CYS B 370 CYS B 389 1555 1555 2.06 SSBOND 8 CYS B 400 CYS B 428 1555 1555 2.05 LINK OE1 GLU B 270 CA CA B 502 1555 1555 2.34 LINK O ASP B 272 CA CA B 502 1555 1555 2.48 LINK O GLU B 275 CA CA B 502 1555 1555 2.28 LINK OE2 GLU B 280 CA CA B 502 1555 1555 2.44 LINK CA CA B 502 O HOH B 656 1555 1555 2.66 LINK CA CA B 502 O HOH B 774 1555 1555 2.49 CISPEP 1 PHE B 465 PRO B 466 0 4.06 SITE 1 AC1 7 ARG A 173 CYS A 174 SER A 179 LEU A 180 SITE 2 AC1 7 HOH A 408 HOH A 411 HOH A 412 SITE 1 AC2 14 LEU B 237 HIS B 253 CYS B 254 ASP B 256 SITE 2 AC2 14 LYS B 257 GLY B 297 CYS B 400 LYS B 401 SITE 3 AC2 14 SER B 404 SER B 423 TRP B 424 GLY B 427 SITE 4 AC2 14 HOH B 616 HOH B 693 SITE 1 AC3 6 GLU B 270 ASP B 272 GLU B 275 GLU B 280 SITE 2 AC3 6 HOH B 656 HOH B 774 SITE 1 AC4 2 ARG B 262 VAL B 459 SITE 1 AC5 5 MET B 366 THR B 367 ARG B 439 HOH B 604 SITE 2 AC5 5 HOH B 686 SITE 1 AC6 5 HOH A 411 SER B 453 GLU B 454 HOH B 647 SITE 2 AC6 5 HOH B 751 CRYST1 95.037 95.037 116.512 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010522 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010522 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008583 0.00000